We are live on ! Find out more

28 hedge funds and large institutions have $735K invested in PAVmed in 2025 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 1 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

500% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 1

0.01% less ownership

Funds ownership: 0.25%0.24% (-0.01%)

3% less funds holding

Funds holding: 2928 (-1)

16% less capital invested

Capital invested by funds: $873K → $735K (-$138K)

25% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 4

Holders
28
Holders Change
-1
Holders Change %
-3.45%
% of All Funds
0.37%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
6
Reduced
1
Closed
4
Calls
Puts
Net Calls
Net Calls Change

PAVM Hedge Fund Activity: Q2 2025 in Review

28 of the 7,598 institutional investors tracked by Wall St. Rank reported a position in PAVmed (PAVM) for Q2 2025, worth a combined $735K — down 16% from $873K a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of PAVM and 3 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 6 added.

The largest buyer was Jane Street, adding an estimated $28K. The largest seller was XTX Topco, exiting entirely with an estimated $16.9K sold.

  • 28 institutional investors held PAVmed (PAVM) as of Q2 2025, down from 29 in Q1 2025.
  • Funds reported $735K of PAVmed stock for Q2 2025, down 16% quarter-over-quarter.
  • 3 funds opened new PAVmed positions in Q2 2025 and 4 closed out, a net change of -1 holder.
  • The largest PAVmed buyer in Q2 2025 was Jane Street, an estimated $28K added.
  • The largest PAVmed seller in Q2 2025 was XTX Topco, an estimated $16.9K sold.

Based on aggregated 13F filings for Q2 2025.